Skip to main content

HOPA Abstracts

Encorafenib plus Cetuximab, with or without Binimetinib, for BRAF V600E–Positive Metastatic Colorectal Cancer: Relationship Between Carcinoembryonic Antigen and Clinical Outcomes from BEACON CRC
Abstract #CT06
Read More
Cost of Cancer Management by Stage of Diagnosis Among Medicare Beneficiaries
Abstract #CT05
Read More
Corticosteroid Tapering in Patients with Relapsed or Refractory Multiple Myeloma Receiving Subcutaneous Daratumumab: Part 3 of the Open-Label, Multicenter, Phase 1b PAVO Study
Abstract #CT04
Read More
Correlation of BRAF Mutation Status in Circulating Tumor DNA with Tumor Biopsy and Clinical Outcomes in the COLUMBUS Study
Abstract #CT03
Read More
Continuous Pre-Dose Assessment of Laboratory Parameters Is Not Required for Patients with Multiple Myeloma Receiving Lenalidomide, Bortezomib, and Dexamethasone
Abstract #CT02
Read More
HOPA 2020 Abstracts, Part IV
Read More
HOPA 2020 Abstracts, Part III
Read More
HOPA 2020 Abstracts, Part II
Read More
HOPA 2020 Abstracts
Read More
Page 12 of 12
Results 111 - 119 of 119